Mincheng Yu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Immune cells in cancer
Papers in
-
- Circular RNAs in diseases 2
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Qing‐Hai Ye (16 shared papers)Binghai Zhou (11 shared papers)Jia Fan (12 shared papers)Yong‐Sheng Xiao (15 shared papers)Yongfeng Xu (11 shared papers)Zheng Chen (11 shared papers)Jiuliang Yan (11 shared papers)Zhangfu Yang (8 shared papers)
In The Last Decade
Mincheng Yu
29 papers receiving 481 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 128
- Immunology 100
- Oncology 119
- Molecular Biology 194
- Hepatology 19
Countries citing papers authored by Mincheng Yu
This map shows the geographic impact of Mincheng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mincheng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mincheng Yu more than expected).
Fields of papers citing papers by Mincheng Yu
This network shows the impact of papers produced by Mincheng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mincheng Yu. The network helps show where Mincheng Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mincheng Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. | 2019 | 70 |
| 2 | 2022 | 61 | |
| 3 | 2020 | 53 | |
| 4 | 2021 | 38 | |
| 5 | 2018 | 34 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 21 | |
| 8 | 2022 | 21 | |
| 9 | 2024 | 17 | |
| 10 | 2020 | 17 | |
| 11 | GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma. | 2020 | 16 |
| 12 | 2022 | 15 | |
| 13 | 2022 | 15 | |
| 14 | 2019 | 14 | |
| 15 | 2020 | 14 | |
| 16 | 2020 | 9 | |
| 17 | 2022 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2025 | 5 |
About Mincheng Yu
Mincheng Yu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Electrical and Electronic Engineering, having authored 34 papers that have together received 484 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), MicroRNA in disease regulation (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer Mechanisms and Therapy (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Ferroptosis and cancer prognosis (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (128 citations), Immunology (100 citations), Oncology (119 citations), Molecular Biology (194 citations) and Hepatology (19 citations). Mincheng Yu has collaborated with scholars based in China, Taiwan and Ethiopia. Frequent co-authors include Qing‐Hai Ye, Binghai Zhou, Jia Fan, Yong‐Sheng Xiao, Yongfeng Xu, Zheng Chen, Jiuliang Yan, Zhangfu Yang, Lei Guo and Kewei Zhang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Carcinogenesis, Annals of Translational Medicine, Journal of Hepatology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.